SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression

BACKGROUND & AIMS: SCY1-like pseudokinase 3 (SCYL3) was identified as a binding partner of ezrin, implicating it in metastasis. However, the clinical relevance and functional role of SCYL3 in cancer remain uncharacterized. In this study, we aimed to elucidate the role of SCYL3 in the progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Martina Mang Leng, Leung, Carmen Oi Ning, Lau, Eunice Yuen Ting, Leung, Rainbow Wing Hei, Ma, Victor Wan San, Tong, Man, Lu, Yin Ying, Huang, Chen Yang, Zhu, Qiao Hua, Ng, Irene Oi Lin, Ma, Stephanie, Lee, Terence Kin Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691429/
https://www.ncbi.nlm.nih.gov/pubmed/36440258
http://dx.doi.org/10.1016/j.jhepr.2022.100604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691429/
https://www.ncbi.nlm.nih.gov/pubmed/36440258
http://dx.doi.org/10.1016/j.jhepr.2022.100604

Ejemplares similares